Mounjaro injection sites for weight loss: where to inject and why rotation matters

Three licensed injection sites: abdomen, front of thigh, and outer upper arm — each delivers tirzepatide reliably into subcutaneous fat.
Rotate the site every week; using the same spot repeatedly can cause lipohypertrophy (a lump of hardened fat tissue) that slows absorption.
Avoid injecting into skin that is bruised, scarred, tender or affected by a rash, the Mounjaro SmPC on the eMC details these precautions precisely.
The injection must go into subcutaneous fat, not muscle, pinching the skin slightly before pressing the KwikPen helps if you have less body fat to work with.

The three licensed sites for Mounjaro injections are the abdomen, the front of the thigh, and the upper arm — all deliver the medicine effectively for weight loss when used correctly. Rotating between them each week reduces the risk of skin changes at any single spot and keeps absorption consistent. Mounjaro (tirzepatide) is a prescription-only medicine; a full overview of Mounjaro covers eligibility and how it works. A prescriber assesses suitability before treatment begins, and the Patient Information Leaflet supplied with your pen is the definitive reference for injection technique.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Getting injection sites right from your very first Mounjaro pen

The myth that one site works better than the others for faster results

It comes up regularly: people wonder whether injecting into the stomach gives quicker or stronger results than the thigh or arm. The honest answer is that the clinical evidence does not support picking one site over another for weight-loss speed. What the research and the licensed guidance both confirm is that all three approved locations (abdomen, front of the thigh, outer upper arm) deliver tirzepatide into subcutaneous fat reliably, and from there the medicine reaches its target regardless of which you used. The detailed guide to Mounjaro injection sites on this site goes further on the anatomy behind that, but the short version is: site selection is about technique and skin health, not about optimising the medicine's effect.

The bigger practical difference is comfort. Many people find the abdomen easiest to reach and to pinch the skin on, especially in the early weeks when the process still feels unfamiliar. That's completely understandable, self-injecting for the first time is a strange thing to do, and it takes a few pens before it feels routine. The thigh is a good alternative if abdominal skin is sensitive or bruised from a previous dose. The upper arm works well but typically requires a second person or a flat surface to press against if you cannot hold the pen steadily one-handed.

One thing worth noting from the NHS's patient guidance on tirzepatide: do not inject into muscle. The KwikPen is designed for subcutaneous tissue, and a gentle skin-pinch before pressing the device helps ensure the needle reaches the right layer, particularly at leaner injection points like the thigh.

Why rotating sites every week is the rule, not a suggestion

Injecting into the same patch of skin week after week leads to a condition called lipohypertrophy, a build-up of fibrous, fatty tissue under the skin that forms a small lump. Lumps look harmless, but injecting into them slows or unpredictably changes how the medicine is absorbed, which can affect how well treatment works. Rotation prevents this entirely.

A practical system is to divide each site into zones and move around them in a fixed order (left abdomen one week, right abdomen the next, left thigh, right thigh, and so on) and also leave at least two centimetres between any two consecutive spots within the same zone. The guide to choosing the best injection site has a diagram-style explanation of how to map this out if you prefer a visual plan.

Rotation also applies within a site. If you inject exclusively into one small area of the abdomen, you can still develop site changes even though you are technically using the "right" location. Vary the precise spot each time, staying within the broader approved zone. Keep away from the navel by at least two to three centimetres, and avoid the waistline where clothing and movement can cause friction on fresh injection marks.

If you are considering treatment and want to understand more about what the self-injection process actually involves day to day, the Mounjaro injection page walks through the full KwikPen technique in plain language.

Skin preparation, aftercare and when to get medical help

Clean the chosen spot with an alcohol swab and let it dry fully before injecting, damp skin can sting and slightly increase infection risk. Pressing the pen firmly against dry skin and holding it steady until the injection is complete (the KwikPen clicks and then holds for a count of ten) ensures the full dose is delivered. Do not rub the skin afterwards; that can disperse the medicine unevenly into the tissue.

Mild redness, slight bruising or a small welt at the injection site in the first hour or two is common and usually settles on its own. Persistent swelling, warmth that spreads, or a hard lump that does not resolve within a few days are worth flagging to your prescriber. Serious allergic reactions (rapid swelling of the face or throat, difficulty breathing) need emergency care immediately. The MHRA's Yellow Card scheme is there to report suspected side effects from any medicine, including injection-site reactions.

Needles must be changed for each new injection. Reusing a needle blunts the tip, increases discomfort, and raises the risk of infection. If you need a practical supply, replacement needles are available from our pharmacy. Used needles and the pen itself are clinical waste and should go into a sharps container rather than a household bin, a 1-litre sharps container is designed for exactly this.

For a broader picture of how tirzepatide works on appetite and blood-sugar pathways once it is absorbed, the explanation of how Mounjaro works for weight loss is a good next read. And if you are curious about the clinical context (what BMI and health conditions make someone eligible) Mounjaro's licensed uses for weight loss covers the prescribing criteria in detail. For an overview of all the weight-loss treatment options available through our pharmacy, the weight-loss treatments overview lays out the full picture. The decision about whether tirzepatide is the right fit is always made by a prescriber reviewing your individual health profile, not by the site or dose you have read about. If you are ready to start that conversation, you can begin your free consultation at any time.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions